About Journal of Personalized Medicine


Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).

For a comprehensive perspective of primary research, commentaries, and reviews related to personalized medicine, also termed precision medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.


Topics of interest with a view towards personalized medicine include (but are not limited to) the following:

  • Omics-based studies of disease risk, disease prognosis, and response to therapy
  • Biomarker identification and application
  • Drug target discovery and integration with individualized therapy
  • Pharmacogenomics – genetics and biochemistry of drug uptake, action, and metabolism
  • Prediction-based drug safety
  • Novel therapeutics: genetic-based, nanotechnology, targeting strategies
  • Advancements in Technologies and Resources
    • Genetic testing, sequencing technologies, and molecular diagnostics
    • Expression analysis, metabolomics, proteomics
    • Microbiomes
    • Genome-wide association studies
    • Bioinformatics and health informatics
    • Biostatistics
  • Personalization of omics-based non-drug related health interventions
  • Regulation and bioethics in personalized medicine

MDPI Publication Ethics Statement

JPM is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications. MDPI works with Publons to provide reviewers with credit for their work.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

St. Alban-Anlage 66
CH-4052 Basel
E-mail: support@mdpi.com

Copyright / Open Access

Articles published in JPM will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). MDPI will insert the following note at the end of the published text:

© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).


Reprints may be ordered. Please contact publisher@mdpi.com for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is jpm@mdpi.com.

Editorial Office

Dr. Cristina Arimany-Nardi
Managing Editor
MDPI Barcelona office, Avenida Madrid, 95, 08028 Barcelona, Spain

For further MDPI contacts, see here.

Journal Contact

JPM Editorial Office
St. Alban-Anlage 66, 4052 Basel, Switzerland
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18
Editorial Board
Contact Details Submit to JPM
Back to Top